Original language | English |
---|---|
Journal | Annals of the Rheumatic Diseases |
Volume | 70 |
Issue number | 3 (Suppl.) |
Pages (from-to) | 152 |
Number of pages | 1 |
ISSN | 0003-4967 |
Publication status | Published - 2011 |
Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score).
C. Peterfy, P. Emery, P.-P. Tak, Mikkel Østergaard, J. DiCarlo, K. Otsa, F. Navarro Sarabia, K. Pavelka, K. Preston, T. Shaw, M.-A. Bagnard, A. Gabriele